Quercetin and metabolic syndrome: A review

被引:277
作者
Hosseini, Azar [1 ]
Razavi, Bibi Marjan [2 ,3 ]
Banach, Maciej [4 ]
Hosseinzadeh, Hossein [3 ,5 ]
机构
[1] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Targeted Drug Delivery Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Razavi Khorasan, Iran
[4] Med Univ Lodz, Dept Hypertens, Lodz, Poland
[5] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
关键词
diabetes; dyslipidemia; hypertension; metabolic syndrome; obesity; quercetin; HIGH-FAT DIET; FLAVONOID QUERCETIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; BLOOD-PRESSURE; INDUCED INFLAMMATION; LIPID-METABOLISM; DOUBLE-BLIND; RISK-FACTORS; ANTIOXIDANT;
D O I
10.1002/ptr.7144
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the development of cardiovascular problems. Quercetin, as an important flavonoid, has various properties such as decreasing blood pressure, anti-hyperlipidemia, anti-hyperglycemia, anti-oxidant, antiviral, anticancer, anti-inflammatory, anti-microbial, neuroprotective, and cardio-protective effects. In this review article, we collected original articles from different sources such as Google Scholar, Medline, Scopus, and Pubmed, which is related to the effect of quercetin on the improvement of the signs of MetS, including elevated glucose level, hyperlipidemia, obesity, and blood pressure. According to these data, quercetin may also have a role in the management of metabolic disorders via different mechanisms such as increasing adiponectin, decreasing leptin, anti-oxidant activity, reduction of insulin resistance, the elevation of insulin level, and blocking of calcium channel. We have attempted to make some recommendations on the quercetin application in patients. However, it needs to do further clinical trials and more investigations to show the real clinical value of quercetin on metabolic syndrome.
引用
收藏
页码:5352 / 5364
页数:13
相关论文
共 50 条
[41]   A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome [J].
B. M. Razavi ;
H. Hosseinzadeh .
Journal of Endocrinological Investigation, 2014, 37 :1031-1040
[42]   Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review [J].
Yarmohammadi, Fatemeh ;
Rahbardar, Mahboobeh Ghasemzadeh ;
Hosseinzadeh, Hossein .
IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 24 (04) :420-427
[43]   Natural products for managing metabolic syndrome: a scoping review [J].
Abdulghani, Mohammed Faris ;
Al-Fayyadh, Sadeq .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[44]   A New Perspective on Metabolic Syndrome with Osteopontin: A Comprehensive Review [J].
Cicekli, Ipek ;
Saglam, Duygu ;
Takar, Nadir .
LIFE-BASEL, 2023, 13 (07)
[45]   Yoga as a complementary therapy for metabolic syndrome: A narrative review [J].
Khoshnaw, Dastan M. ;
Ghadge, Abhijit A. .
JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (01) :6-12
[46]   A Review on the Protective Effects of Honey against Metabolic Syndrome [J].
Ramli, Nur Zuliani ;
Chin, Kok-Yong ;
Zarkasi, Khairul Anwar ;
Ahmad, Fairus .
NUTRIENTS, 2018, 10 (08)
[47]   Metabolic Syndrome: The Constellation of Co-morbidities, A Global Threat [J].
Madan, Kirtika ;
Paliwal, Sarvesh ;
Sharma, Swapnil ;
Kesar, Seema ;
Chauhan, Neha ;
Madan, Mansi .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (12) :1491-1504
[48]   α-Lipoic acid:: physiologic mechanisms and indications for the treatment of metabolic syndrome [J].
Pershadsingh, Harrihar A. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) :291-302
[49]   Metabolic Syndrome Programming and Reprogramming: Mechanistic Aspects of Oxidative Stress [J].
Tain, You-Lin ;
Hsu, Chien-Ning .
ANTIOXIDANTS, 2022, 11 (11)
[50]   Promising Influences of Moringa oleifera in Functional Foods against Metabolic Syndrome: A Comprehensive and Mechanistic Review [J].
Masoumvand, Mohammad ;
Ramezani, Elmira ;
Rahimi, Vafa Baradaran ;
Askari, Vahid Reza .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024, 24 (12) :1355-1370